Clinical Trials Logo
  1. Home
  2. Non Alcoholic Fatty Liver
  3. NCT02030977

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Non Alcoholic Fatty Liver Clinical Trial

Official title:
The Effects of Resveratrol Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Clinical Trial Summary

To study the effects of Resveratrol supplement on lipid profile, liver enzymes, inflammatory factors and hepatic fibrosis in patients with Nonalcoholic Fatty Liver (NAfLD), 50 patients who referred to Gastrointestinal (GI) clinic with steatosis grade 1 or more will be randomly allocated to receive 1 Resveratrol capsules or placebos for 12 weeks; both groups will be advised to adherence our diet and exercise program too. At the first and the end of the intervention, lipid profiles, liver enzymes, some inflammatory cytokines, and liver fibrosis will be assessed and compared between groups.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02030977
Study type Interventional
Source National Nutrition and Food Technology Institute
Contact
Status Completed
Phase Phase 2/Phase 3
Start date June 2012
Completion date March 2013
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03625284 - Oral Dietary Fucoxanthin Rich Supplement for Liver Health N/A
Completed NCT02923804 - Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients N/A
Completed NCT03222206 - The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease Phase 4
Completed NCT04823676 - Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management N/A
Completed NCT03186859 - Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) N/A
Recruiting NCT06176079 - Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Not yet recruiting NCT06138821 - ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial Phase 4
Not yet recruiting NCT04553796 - Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
Not yet recruiting NCT03801577 - Hepaxa Management of Non-alcoholic Fatty Liver Disease N/A
Completed NCT05804422 - Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) N/A
Recruiting NCT04625166 - Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
Recruiting NCT05523024 - Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL. N/A
Not yet recruiting NCT05822622 - Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.